Skip to content
Home page - Centenary Institute Centenary Institute

Primary menu

  • Research
        • Research

          The latest medical research into our most complex health challenges across cancer, cardiovascular disease and inflammation

          Learn more

        • Cancer
        • Inflammation
        • Cardiovascular
        • Programs
        • Laboratories
        • Diseases
        • Expertises
        • Services and instrumentation
  • Support us
        • Support us

          By supporting the Centenary Institute you can help improve human health through excellence in medical research

          Learn more

        • Workplace giving
        • Host or join a fundraiser
        • Gift in your will
        • Donate in Memory
  • Impact
        • Impact

          Our research develops new diagnostics, treatments and cures for some of the most deadly and debilitating diseases affecting society today

          Learn more

        • Breakthroughs
        • Community and research
  • Careers & studies
        • Careers & Studies

          Take the next step in your career with Centenary, Australia’s foremost clinically integrated medical research institute

          Learn more

        • Career opportunities
        • Life at Centenary
        • Post-Doctorate Research
        • PhD
        • Masters
        • Honours
  • News & events
        • News & Events

          Explore the latest research breakthroughs and ways you can take part in our series of digital and in-person events

        • News
        • Events
        • Media Hub
  • About us
        • About us

          We are world-leading independent medical research institute that drives collaboration to accelerate and translate solutions to our most complex health challenges

          Learn more

        • Governance
        • Corporate information
        • Annual reports
        • Our researchers
        • Contact
  • Donate
    Centenary Institute > News > New insight into the immune system

New insight into the immune system

Date time 6 July, 2020
News Type News type Research News
New research from the Centenary Institute has provided novel insights into the role of these spacer DNA or introns in the development and function of monocytes and macrophages, essential components of the innate immune system.

Our DNA is like an encyclopaedia and genes are like the paragraphs. Like paragraphs, which are separated by spaces, our genes also contain ‘spacer DNA’, known scientifically as ‘introns’. For genes to be expressed properly, and to carry out biological functions, spacer DNA or introns need to be removed. New research from the Centenary Institute has provided novel insights into the role of these spacer DNA or introns in the development and function of monocytes and macrophages, essential components of the innate immune system.

Monocytes, white blood cells that undergo changes to become macrophages when they travel from the bloodstream into tissue, help protect the body by seeking out and destroying microbes, foreign substances and diseased cells.

Led by senior researcher Dr Justin Wong, Head of the Epigenetics and RNA Biology Program at the Centenary Institute (pictured right), the team has discovered that through a process called ‘intron retention’ by which spacer DNA  are purposely maintained, monocytes and macrophages can control the expression of key genes involved in their development and critical pathogen-fighting activities.

“We discovered that these spacer sequences are deliberately retained in some cases to suppress the function of genes when they were not needed. One class of genes that are regulated this way are genes that promote the innate immune response, and control monocyte and macrophage activity. By retaining introns, partially-ready genes accumulate in the cells and await signals that pathogens are present.” said Dr Wong.

“Once an appropriate signal is detected, the spacer DNA or introns in these immune genes will be removed rapidly to reinstate their functions. Thus, there is a ‘volley’ effect to enhance the innate immune response to get rid of the pathogens quickly,” added Immanuel Green (pictured left), the lead author and a postgraduate student in Dr Wong’s lab.

Dr Wong notes that the published study provides novel insights into the molecular factors controlling vital regulators of the innate immune response system.

“Further investigation into the mechanisms that underpin this phenomenon will enable a better understanding of diseases characterised by aberrant macrophage function. Diseases include a range of vasculature, lung, body fat and kidney inflammatory pathologies,” he says.

The study, published in the journal Nucleic Acids Research, can be accessed here.

Information on Dr Wong and his research can be found here.

Themes

  • Cancer

    Cancer

Media enquires

For all media and interview enquiries, please contact Tony Crawshaw, Media and Communications Manager

Phone number Phone Number 0402 770 403

Email Email t.crawshaw@centenary.org.au

Recent Stories

  • New drug target identified for inflammatory lung disease

    Researchers at the Centenary Institute and the University of Technology Sydney have identified a new drug target for the treatment and prevention of chronic obstructive pulmonary disease (COPD), an inflammatory lung disease that causes airway blockage and that makes it difficult to breathe.
    News Type: Media release
    Date 04 Jul 2022
  • Inflammation presentation awarded

    Dr Joyce Chiu from the ACRF Centenary Cancer Research Centre has won an Oral Communication Award for her talk given at the 15th World Congress on Inflammation, held in Rome, June 2022.
    News Type: Research News
    Date 01 Jul 2022
  • Meet Dr Annalicia Vaughan

    A medical researcher at the Centenary UTS Centre for Inflammation, Dr Annalicia Vaughan specialises in the gut-lung axis and its role in lung and respiratory diseases.
    News Type: Profiles
    Date 28 Jun 2022
    Dr Vaughan
  • The Centenary Institute is excited to join the Sydney Biomedical Accelerator (SBA) as primary medical research partner

    The Centenary Institute welcomes the NSW Government’s commitment to fund a new biomedical complex in Camperdown. The Chair of the Centenary Institute Board, Joseph Carrozzi AM, and its Executive Director, Professor Mathew Vadas AO, are thrilled that a biomedical complex, the Sydney Biomedical Accelerator (SBA), will now be a reality.
    News Type: Media release
    Date 17 Jun 2022

Subscribe to receive news on
research updates and free events

Newsletter

The Centenary Institute is a world-leading independent Medical Research Institute.

We acknowledge the Gadigal of the Eora Nation, the traditional custodians of the Country on which the Centenary Institute stands.

About

  • About
  • Governance
  • Corporate information

Research

  • Programs
  • Laboratories
  • Our researchers
  • News
  • Media hub

Careers & studies

  • Career opportunities
  • Life at Centenary

Links

  • Contact
  • Privacy statement

Contact us

Building 93, Royal Prince Alfred Hospital
Missenden Rd
Camperdown NSW 2050 Australia
Telephone +61 2 9565 6100
Fax +61 2 9565 6101

Centenary Institute ABN 22 654 201 090 (DGR 1) • Centenary Institute Medical Research Foundation ABN 85 778 244 012 (DGR 2)
© 2017 Centenary Institute of Cancer Medicine and Cell Biology.

  • Linkedin
  • Facebook
  • Twitter
  • Youtube
  • Instagram